Hypothalamic inflammation is a key component of acute sickness behavior and cachexia, yet mechanisms of inflammatory signaling in the central nervous system remain unclear. Previous work from our lab and others showed that while MyD88 is an important inflammatory signaling pathway for sickness behavior, MyD88 knockout (MyD88KO) mice still experience sickness behavior after inflammatory stimuli challenge. We found that after systemic lipopolysaccharide (LPS) challenge, MyD88KO mice showed elevated expression of several cytokine and chemokine genes in the hypothalamus. We therefore assessed the role of an additional inflammatory signaling pathway, TRIF, in acute inflammation (LPS challenge) and in a chronic inflammatory state (cancer cachexia). TRIFKO mice resisted anorexia and weight loss after peripheral (intraperitoneal, IP) or central (intracerebroventricular, ICV) LPS challenge and in a model of pancreatic cancer cachexia. Compared to WT mice, TRIFKO mice showed attenuated upregulation of Il6, Ccl2, Ccl5, Cxcl1, Cxcl2, and Cxcl10 in the hypothalamus after IP LPS treatment, as well as attenuated microglial activation and neutrophil infiltration into the brain after ICV LPS treatment. Lastly, we found that TRIF was required for Ccl2 upregulation in the hypothalamus and induction of the catabolic genes, Mafbx, Murf1, and Foxo1 in gastrocnemius during pancreatic cancer. In summary, our results show that TRIF is an important inflammatory signaling mediator of sickness behavior and cachexia and presents a novel therapeutic target for these conditions.
Introduction
Innate immune activation in response to various pathogens leads to systemic and central nervous system (CNS) inflammation, inducing a distinct metabolic and behavioral paradigm that includes fever, weight loss, anorexia, and fatigue. This constellation of signs and symptoms, referred to as "sickness behavior" (Dantzer et al., 1998) , is critical for combating infection and allows resources to be diverted to the immune system to fight pathogens. However, if sickness behavior is maintained in conditions of chronic inflammation, it can become maladaptive and manifest as cachexia. Cachexia is a devastating syndrome characterized by anorexia, increased catabolism of lean body mass, and lethargy (Argiles et al., 2010; Evans et al., 2008; Fearon et al., 2011) . It is prevalent in numerous chronic diseases, including cancer (Tisdale, 2002) , chronic renal failure (Wang et al., 2004) , congestive heart failure (Anker et al., 1997) , and untreated HIV (Kotler et al., 1989) . Furthermore, cachexia is associated with increased mortality of the underlying disease and decreased quality of life (Bachmann et al., 2008; WesseltoftRao et al., 2015; Lainscak et al., 2007) . Despite this serious clinical concern, there are currently no effective treatments and mechanisms remain controversial.
Our lab, along with others, described a CNS-based mechanism of cachexia in which cytokines generated in the periphery are amplified and modified within the hypothalamus, leading to aberrant activity of weight-and activity-modulating neurons Burfeind et al., 2015; Bluthé et al., 2000) . Specifically, intracerebroventricular (ICV) injection of inflammatory cytokines (Sonti et al., 1996; Bodnar et al., 1989) or pathogen associated molecular patterns such as lipopolysaccharide (LPS) (Wisse et al., 2007) potently reduces food intake and activity. Furthermore, peripheral or central cytokine injection or immune challenge leads to rapid activation of neurons in areas that are critical for food intake and energy metabolism, such as the nuclei of the mediobasal hypothalamus (MBH) (Elmquist et al., 1996; Konsman et al., 2000; Laflamme and Rivest, 1999; Morgan and Curran, 1986 ).
However, the cellular and molecular pathways whereby peripheral inflammation is translated in the brain into behavioral or metabolic responses are still not well understood.
Toll-like receptors (TLRs) are key components of the innate immune system, recognizing a variety of pathogens and inflammatory signals. TLR function is important for mounting an appropriate inflammatory response, and metabolic signaling in the CNS is closely tied to TLR signaling (Jin et al., 2016) . Pro-inflammatory signaling via the Myeloid Differentiation Primary Response Gene 88 (MyD88) pathway was initially thought to be the dominant mechanism whereby the binding of pathogenic signaling molecules to receptors is linked to the synthesis and release of inflammatory cytokines and chemokines (Medzhitov et al., 1998) . However, recent data suggest that MyD88-independent pathways linking TLRs to cellular activation are present within the brain (Hanke and Kielian, 2011; Lin et al., 2012) . In our previous work, we found that while sickness behavior was severely attenuated in MyD88KO mice, a slight anorexia response was present and muscle catabolism occurred (Braun et al., 2013) . The adaptor protein TIR-domain-containing adaptor inducing interferon-β (TRIF) is an important inflammatory signaling mediator, yet has received little attention in the context of CNS-mediated alterations in behavior and metabolism during illness. TRIF is the dominant adapter for TLR3 signaling, and plays an essential role in TLR4 responses to LPS as well (Yamamoto et al., 2003) . Furthermore, TRIF knockout (TRIFKO) mice are nearly as resistant to endotoxin-induced mortality as are MyD88KO mice (Feng et al., 2011) .
The role of TRIF signaling in the CNS during acute sickness behavior and cachexia is unknown. We found that TRIF signaling is important for neuroinflammation and resulting acute sickness behavior after systemic or central exposure to LPS. We also found that mice lacking TRIF have attenuated cancer cachexia. These results implicate TRIF as a key signaling mediator in inflammation-driven behavioral and metabolic changes during illness, and a potential therapeutic target for cachexia.
Materials and methods

Animals
Male and female 20-25-g WT C57BL/6J (stock no. 000664), MyD88KO (stock no. 009088), TRIFKO (Trif Lps2 , stock no. 005037) mice were obtained from The Jackson Laboratory. No immune, developmental, or behavioral abnormalities were observed in TRIFKO mice by our group, consistent with the existing literature (Yamamoto et al., 2003; Zhu et al., 2016) . Furthermore, they consume the same amount of food as WT animals in the absence of inflammation (see Figs. 2 and 3), and their spleens are the same size (data not shown). Mice were between 7 and 12 weeks of age at time of experiment. All animals were maintained at 27°C on a normal 12:12 h light/dark cycle and provided ad libitum access to water and food. Experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and approved by the Animal Care and Use Committee of Oregon Health and Science University.
Intracerebroventricular cannulation and Injections
Mice were anesthetized under isoflurane and placed on a stereotactic alignment instrument (Kopf Instruments, CA). 26-gauge lateral ventricle cannulas were placed at −1.0 mm X, −0.5 mm Y, and −2.25 mm Z relative to bregma. Injections were given in 2 µL total volume. LPS (from Escherichia coli, O555:B5, Sigma Aldrich, St. Louis, MO) was dissolved in normal saline with 0.5% bovine serum albumin.
Nocturnal feeding studies
Animals were transferred to clean cages and injected with ICV (50 ng) or IP (250 μg) LPS 1 h prior to lights off. At 2, 6, 12, 24, 36 and 48 hrs after the onset of the dark cycle, food was weighed and returned to the cage. Body weight was recorded at 12, 24, 36, and 48 hrs.
Plasma corticosterone measurement
Plasma corticosterone levels were measured by RIA (MP Biomedicals, Valiant, Yantai, China) according to the manufacturer's instructions. Animals were anesthetized with a lethal dose of a ketamine/xylazine/acetapromide 4 h after IP LPS administration. Blood was obtained by cardiac puncture, anticoagulated with EDTA and separated by centrifugation. Plasma was stored at −80°C until analysis.
Quantitative real-time PCR
Prior to tissue extraction, mice were euthanized with a lethal dose of a ketamine/xylazine/acetapromide and sacrificed. Hypothalamic blocks were dissected, snap frozen, and stored in −80°C until analysis. Hypothalamic RNA was extracted using an RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. cDNA was transcribed using TaqMan reverse transcription reagents and random hexamers according to the manufacturer's instructions. PCR reactions were run on an ABI 7300 (Applied Biosystems, Foster City, CA), using TaqMan universal PCR master mix with the following TaqMan mouse gene expression assays, selected based on previous studies from our lab and others which showed their importance in sickness behaviors and cachexia Zhu et al., 2016; Le Thuc et al., 2017) :
, and Foxo1 (Mm00490672_m1). It is important to note that Ifnβ is a single exon gene and therefore results may be confounded by genomic DNA. However, we used DNAse to eliminate genomic DNA and also ran a noprimer control, which showed no amplification (not shown).
Relative expression was calculated using the ΔΔCt method and normalized to WT vehicle treated or sham control. Statistical analysis was performed on the normally distributed ΔCt values.
Immunohistochemistry
Mice were anesthetized using a ketamine/xylazine/acetapromide cocktail and sacrificed by transcardial perfusion fixation with 15 mL ice cold 0.01 M PBS followed by 25 mL 4% paraformaldehyde (PFA) in 0.01 M PBS. Brains were post-fixed in 4% PFA overnight at 4°C and cryoprotected in 20% sucrose for 24 h at 4°C before being stored at −80°C until used for immunohistochemistry. Immunofluorescence histochemistry was performed as described below. Free-floating sections were cut at 30 μm from perfused brains using a sliding microtome (Leica SM2000R, Leica Microsystems, Wetzlar, Germany). Hypothalamic sections were collected from the division of the optic chiasm (bregma −1.0 mm) caudally through the mammillary bodies (bregma −3.0 mm). Sections were incubated for 30 min at room temperature in blocking reagent (5% normal donkey serum in 0.01 M PBS and 0.3% Triton X-100). After the initial blocking step, sections were incubated in rabbit anti-mouse Iba-1 (1:500, DAKO) in blocking reagent for 24 h at 4°C, followed by incubation in donkey anti-rabbit Alexa 555 (1:1000) for 2 h at room temperature. Between each stage, sections were washed thoroughly with 0.01 M PBS. Sections were mounted onto gelatin-coated slides and coverslipped using Prolong Gold Antifade media with DAPI (Thermofisher, Waltham, MA).
Microglia activation quantification
Microglia activation in the MBH was quantified using Fiji (ImageJ, K.G. Burfeind et al. Brain, Behavior, and Immunity xxx (xxxx) xxx-xxx NIH, Bethesda, MD). The MBH was defined as the region surrounding the third ventricle at the base of the brain, starting rostrally at the end of the optic chiasm when the arcuate nucleus appears (−1.22 mm from bregma) and ending caudally at the mammillary body (−2.70 mm from bregma). Images were acquired using the 20× objective (na = 0.8, step size = 1 µm) with a 10× ocular zoom, resulting in 200× magnification. The base of the MBH was positioned at the very bottom of the field of view (FOV) and the third ventricle at the center of the FOV. Care was taken to exclude the meninges so as to avoid analysis of meningeal macrophages. Images were 2048 × 2048 pixels, with a pixel size of 0.315 μm. Images were acquired as 8-bit RGB TIFF images. 3-10 MBH images per animal were acquired and analyzed by a researcher blinded to genotype and treatment group (KGB). After image acquisition, TIFF images were uploaded to Fiji and converted to 8-bit greyscale images. After thresholding, microglia were identified using the Analyze Particle function, which measured mean Iba-1 fluorescent intensity per cell and cell area. Iba-1 fluorescent intensity and cell size was measured for each microglia in the arcuate nucleus. Due to the density of microglia in the median eminence (ME), the software was unable to differentiate individual cells. As such, overall Iba-1 fluorescent intensity was measured to quantify microglia activation in the ME.
Flow cytometry
12 h after 500 ng ICV LPS administration, mice were anesthetized using a ketamine/xylazine/acetapromide cocktail and perfused with 15 mL ice cold 0.01 M PBS to remove circulating leukocytes. After perfusion, brains were extracted and minced in a digestion solution containing 1 mg/mL type II collagenase (Sigma) and 1% DNAse (Sigma) in RPMI, then placed in a 37°C incubator for 1 h. After digestion, myelin was removed via using 30% percoll in RPMI. Isolated cells were washed with RPMI, incubated in Fc block for 5 min, then stained with the following antibodies (all rat anti-mouse from BioLegend, except for Live/Dead) (BioLegend, San Diego, CA): anti-CD45 PerCP/Cy5.5 (1:400), anti-CD11b APC (1:800), anti-Ly6C PerCP (1:100), anti-Ly6G PE/Cy7 (1:800), anti-CD3 PE (1:100), and Live/Dead fixable aqua (1:200, Thermofisher). Flow cytometry was conducted using a Fortessa analytic flow cytometer (BD Biosciences, NJ), and analysis was performed on FlowJo V10 software (FlowJo, Ashland, OR). Cells were gated on LD, SSC singlet, and FSC singlet ( Fig. 3 -figure supplement 1 cells were identified as T-cells.
KPC cancer cachexia model
Our lab generated a mouse model of pancreatic ductal adenocarcinoma (PDAC) -associated cachexia by injection of murine-derived KPC PDAC cells (originally provided by Dr. Elizabeth Jaffee from Johns Hopkins) (Michaelis et al. 2017 ). These cells are derived from tumors in mice with KRAS G12D and TP53 R172H deleted via the PDX-1-Cre driver (Foley et al. 2015) . Cells were maintained in RPMI supplemented with 10% heat-inactivated FBS, and 50 U/mL penicillin/streptomycin (Gibco, Thermofisher, Waltham, MA), in incubators maintained at 37°C and 5% CO 2 . In the week prior to tumor implantation, animals were transitioned to individual housing to acclimate to experimental conditions. Animal food intake and body weight were measured once daily.
Mice were inoculated orthotopically with 3 million KPC tumor cells in 40 μL PBS into the tail of the pancreas (Chai et al., 2013) . Sham-operated animals received heat-killed cells in the same volume. Nuclear Magnetic Resonance (NMR) measurements were taken at the beginning of the study for covariate adaptive randomization of tumor and sham groups to ensure equally distributed weight and body composition. Voluntary home cage locomotor activity was measured via MiniMitter tracking devices (Starr Life Sciences, Oakmont, PA). We only analyzed dark phase activity, based on the nocturnal nature of mice (Bains et al., 2017) and our previous studies that revealed little activity during the light phase (Michaelis et al., 2017) , most of which was likely caused by humans entering the room. Mice were implanted 7 days prior to tumor implantation with MiniMitter transponders in the intrascapular subcutaneous space. Using these devices, movement counts in x-axis, yaxis, and z-axis were recorded in 5 min intervals. Bedding was sifted daily for any chow that may have fell to the cage floor. At 10 days post inoculation, a point when animals consistently develop cachexia (Michaelis et al. 2017) , animals were euthanized, and tissues were extracted for analysis.
Statistical analysis
Data are expressed as means ± SEM. Statistical analysis was performed with Prism 7.0 software (Graphpad Software Corp, La Jolla, CA). All data were analyzed with Two-way ANOVA analysis. For single time point experiments, the two factors in ANOVA analysis were genotype (WT vs TRIFKO in all experiments) or treatment (Saline vs LPS in K.G. Burfeind et al. Brain, Behavior, and Immunity xxx (xxxx) xxx-xxx Figs. 1-4 or Sham vs Tumor in Fig. 5 ). In repeated measures experiments (time course experiments -Figs. 2A and B, 3A and B, 5A and C), the two factors were group and time. Main effects of genotype, treatment, group, time, and/or interaction were first analyzed, and if one effect was significant, Bonferroni post hoc analysis was then performed. For all analyses, significance was assigned at the level of p < 0.05.
Results
MyD88KO mice experience hypothalamic inflammation after systemic LPS challenge.
Based on our previous work showing that MyD88KO mice still show subtle signs of sickness behavior after systemic LPS challenge (slight anorexia, muscle catabolism, and induction of catabolic genes) (Braun et al., 2013) , we hypothesized that hypothalamic inflammation also occurred in these mice. We found that 6 hrs after 250 μg/kg IP LPS, MyD88KO mice showed increased expression of several cytokine and chemokine genes in the hypothalamus, including Il1β, Tnf, Il6, Ifnβ, Ccl2, Ccl5, Cxcl1, Cxcl2, and Cxcl10 ( Fig. 1) (Two way ANOVA treatment effect all at least p < 0.001, post hoc analysis of MyD88KO saline vs. MyD88KO LPS all at least p < 0.01). While upregulated in LPStreated WT mice, Cd80 was not significantly upregulated in LPS-treated MyD88KO mice (treatment F1,12 = 23.28, p < 0.001; genotype F1,12 = 15.14, p = 0.002; interaction F1,12 = 19.16, p < 0.001. WT saline vs. WT LPS p < 0.001, MyD88KO saline vs. MyD88KO LPS p > 0.99 in post hoc analysis). It is important to note that the vast majority of LPS-induced cytokine and chemokine gene upregulation in the hypothalamus was attenuated in MyD88KO mice. Interestingly, Ifnβ only showed a slight non-significant increase in LPS-treated WT mice compared to saline-treated WT mice, yet showed a 3.9-fold upregulation in LPS-treated MyD88KO mice compared to saline-treated MyD88KO mice (treatment effect F1,12 = 8.83, p = 0.01, WT saline vs. WT LPS p = 0.75. MyD88KO saline vs. MyD88KO LPS p = 0.01 in post hoc analysis). Basal expression of all cytokines/chemokines was detectable in hypothalami of saline-treated animals.
Mice lacking TRIF show attenuated acute illness response after systemic LPS challenge
Since MyD88KO mice still show sickness behavior and hypothalamic inflammation after systemic LPS challenge, we hypothesized that other inflammatory signaling pathways are important for TLR4-driven sickness behavior. TRIF is an important adaptor protein for innate immune activation (Yamamoto et al., 2003) , yet its role in sickness behavior after LPS challenge is unknown. After systemic LPS challenge (250 μg/kg, IP), TRIFKO mice showed attenuated anorexia (group effect F3,140 = 312.9, p < 0.001, post hoc analysis of WT LPS vs. TRIFKO LPS at least p < 0.001 every time point after LPS injection) and weight loss (group effect F3,100 = 431.7, p < 0.001, post hoc analysis of WT LPS vs. TRIFKO LPS at least p < 0.01 starting 6 h after LPS injection) compared to WT mice ( Fig. 2A and B) . Next, in order to determine the degree of hypothalamic activation and quantify acute stress response, we measured plasma corticosterone (Gong et al., 2015) . While WT mice showed a large increase in plasma corticosterone 4 hrs after IP LPS administration (p < 0.001), LPS-treated TRIFKO mice did not show a K.G. Burfeind et al. Brain, Behavior, and Immunity xxx (xxxx) (Fig. 2C) . CNS inflammation is a hallmark of acute illness responses and cachexia. Therefore, we measured expression of inflammatory cytokine and chemokine genes in the hypothalamus after systemic LPS challenge using qRT-PCR. We found that 6 h after 250 μg/kg IP LPS, TRIFKO animals showed attenuated up-regulation of several cytokines and chemokines in the hypothalamus, including Il6, Ccl2, Ccl5, Cxcl1, Cxcl2, and Cxcl10 (interaction effect at least p < 0.05) (Fig. 2D) . Alternatively, Il1β, Tnf were not differentially upregulated in LPS-treated TRIFKO mice compared to WT LPS-treated mice (treatment effect p < 0.05, and post hoc analysis comparing saline to LPS-treatment within the same genotype p < 0.05, but interaction effect p > 0.05 for both). In contrast to Fig. 1 , we did not observe a treatment effect of LPS on WT mice for Cd80 (treatment effect F1,12 = 0.68, p = 0.43), yet did see an interaction effect (F1,12 = 6.57, p = 0.02). Lastly, we did not observe any treatment (F1,12 = 0.726, p = 0.411), genotype (F1,12 = 0.346, p = 0.567), or interaction (F1,12 < 0.001, p = 0.995) effect in our analysis of Ifnβ expression in the hypothalamus. It is important to note that basal expression of all cytokines/ chemokines was detectable in hypothalami of saline-treated animals.
In order to rule out altered MyD88 signaling as a result of TRIF deletion, we challenged TRIFKO mice with 10 ng ICV IL-1β. MyD88 is essential for IL-1R signaling, but TRIF is not involved (Muzio et al., 1997) . We found that WT and TRIFKO mice had similar anorexia response to ICV IL-1β (Fig. S1A) . While WT IL-1β-treated mice lost more weight than WT saline-treated mice, it was not significantly more than TRIFKO IL-1β-treated mice. Lastly, Myd88 was equally expressed in WT and TRIFKO mice at baseline, and similarly upregulated after IP LPS exposure (Fig. S1C) .
TRIF is important in acute illness response after ICV LPS challenge
To determine the role of TRIF signaling in the CNS after TLR4 activation, we injected LPS directly into the brain lateral ventricles of WT 
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and TRIFKO mice at a dose that has no behavioral effects when injected peripherally (50 ng). Two-way ANOVA analysis revealed a significant group effect after ICV injection of 50 ng LPS (F3,126 = 313.4, p < 0.001). Subsequent post hoc analysis showed that while LPS caused a significant decrease in cumulative food intake in both WT and TRIFKO animals, starting 36 hrs after treatment TRIFKO animals consumed more than WT animals (p at least < 0.01) (Fig. 3A) . We found similar results when comparing body weight after ICV LPS treatment. Two-way ANOVA analysis revealed a significant group effect after ICV injection of 50 ng LPS (F3,90 = 103.2, p < 0.001), and subsequent post hoc analysis showed that TRIFKO mice treated with ICV LPS experienced significantly attenuated weight loss compared to WT mice treated with ICV LPS at 24 and 36 h after injection (p at least < 0.01) (Fig. 3B) .
TRIF is required for microglial activation after ICV LPS treatment
TRIF is important for microglia function during states of disease (Hosmane et al., 2012) . However, no studies have investigated the role of TRIF in microglial activation after TLR4 stimulation. Therefore, we quantified microglial activation in the MBH 12 h after ICV LPS administration (50 ng) by measuring Iba-1 intensity per cell and cell area. ) may appear compressed in the TRIFKO LPS plot. This is due to the wide range of Ly6G expression on neutrophils, and a nonsignificant increase in Ly6G expression in brain-infiltrating neutrophils in LPS-treated TRIFKO mice (Fig.  S3) . As a result, some neutrophils reached the pre-defined "maximum" fluorescent intensity (10 5.5 ). Any cells with a Ly6G fluorescent intensity greater than this were assigned a fluorescent intensity of 10 
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While arcuate nucleus microglia in LPS-treated WT mice showed a significant increase in size compared to saline-treated WT, arcuate nucleus microglia in LPS-treated TRIFKO mice did not increase in size compared to saline-treated TRIFKO mice (treatment effect F1,12 = 16.73, p = 0.0015, WT saline vs. WT LPS p < 0.01, TRIFKO saline vs. TRIFKO LPS p = 0.32 in post hoc analysis) (Fig. 3E ). In the arcuate nucleus, Iba-1 intensity per microglia did not increase in the LPS-treated group for either genotype (Fig. 3F) . However, overall Iba-1 intensity increased in the median eminence in the WT LPS-treated group compared to the WT saline-treated group, but not in the TRIFKO LPS-treated group compared to the TRIFKO saline-treated group (treatment effect F1,12 = 8.82, p = 0.02, WT saline vs. WT LPS (caption on next page) K.G. Burfeind et al. Brain, Behavior, and Immunity xxx (xxxx) xxx-xxx p < 0.05, TRIFKO saline vs. TRIFKO LPS p > 0.99 in post hoc analysis) (Fig. 3G) .
TRIF is required for neutrophil recruitment to the brain
Since chemokines comprised the majority of inflammatory transcripts that were less upregulated in TRIFKO mice after LPS exposure, we hypothesized that TRIF is important in immune cell recruitment to the brain. We performed flow cytometry on the brains of WT and TRIFKO mice 12 h after 500 ng ICV LPS exposure. We focused our analysis on neutrophils based on previous literature showing they are the predominant cell type in the brain after LPS exposure (He et al., 2016) . We found that, compared to saline-treated WT mice, LPS-treated WT mice had a significantly higher percentage of CD45+ cells in the brain that were neutrophils (treatment effect F1,12 = 18.69, p = 0.001, WT saline vs. WT LPS p = 0.0028 in post hoc analysis) (Fig. 4C) . Alternatively, compared to saline-treated TRIFKO mice, LPStreated TRIFKO mice did not have an increased percentage of CD45+ cells in the brain that were neutrophils (TRIFKO saline vs. TRIFKO LPS p = 0.14) (Fig. 4C) . In WT animals there was a decrease in percentage of CD45+ cells that were T-cells (treatment effect F1,12 = 8.15, p = 0.0145, WT saline vs WT LPS p = 0.019 in post hoc analysis). There was no change in Ly6C low , or Ly6C high monocytes after LPS exposure in either genotype (treatment, genotype, and interaction all p > 0.05 in Two-way ANOVA) (Fig. 4D ).
Mice lacking TRIF have attenuated cancer cachexia
TRIFKO mice inoculated orthotopically with KPC PDAC cells experienced attenuated anorexia compared to WT mice with PDAC ( Fig. 5A and B) . Furthermore, TRIFKO tumor mice showed attenuated voluntary locomotor activity (LMA) compared to WT tumor mice, as defined by dark cycle home cage activity Gabriel Knoll et al., 2017) (Fig. 5C ). While Two-way ANOVA analysis of dark cycle LMA days 3-10 (time from which cachexia response was initiated) revealed a significant group effect (F3, 128 = 45.75, p < 0.001), no post hoc comparisons between the WT tumor and TRIFKO tumor group were significant. However, when Three-way ANOVA analysis was performed (analyzing the effects of tumor status, genotype, and time), the interaction between genotype and tumor status was significant (F = 4.35, df 1,128, p = 0.035). WT tumorbearing mice showed significantly decreased gastrocnemius mass compared to WT sham-operated mice (Two-way ANOVA treatment effect F1,16 = 5.064, p = 0.039, WT sham vs. WT tumor p = 0.022 in post hoc analysis) while TRIFKO tumor-bearing mice did not show decreased gastrocnemius mass compared to TRIFKO sham-operated mice (p > 0.99) (Fig. 5D ). These effects on muscle catabolism were further evidenced by the fact that the E3 ubiquitin-ligase system genes Mafbx and Murf1 were upregulated in WT tumor animals compared to WT sham animals (treatment effect p < 0.001 for all three, post hoc analysis all at least p < 0.01), but not significantly upregulated in TRIFKO tumor-bearing animals (interaction effect at least p < 0.05) (Fig. 5E ). The same was true for Foxo1, a key transcription factor for muscle catabolism (Sandri et al., 2004) . In addition, although Ccl2 was significantly upregulated in the hypothalamus of WT tumor animals compared to sham animals (treatment effect p < 0.01), it was not in TRIFKO tumor-bearing animals (interaction effect p < 0.05). Alternatively, compared to WT tumor-bearing animals, Il1β was equally upregulated in the hypothalami of TRIFKO tumor-bearing animals (treatment effect p < 0.05, but interaction effect p > 0.05), and Tnf, Il6, Cd80, Cxcl1, Cxcl2, and Cxcl10 were not upregulated in the hypothalami WT or TRIFKO tumor-bearing animals. Lastly, although Ccl5 was less upregulated in the hypothalami of TRIFKO tumor-bearing animals compared to WT tumor-bearing animals, this relationship was not significant (interaction effect F1,16 = 1.339, p > 0.05) (Fig. 5F ).
Discussion
We investigated the role of TRIF in acute sickness behavior after LPS exposure and in a model of pancreatic cancer cachexia. These studies demonstrated that TRIFKO mice experienced attenuated sickness behavior after peripheral or central LPS exposure. Furthermore, TRIFKO mice experienced attenuated cachexia during PDAC, including decreased anorexia, voluntary LMA, muscle catabolism, and hypothalamic inflammation relative to WT counterparts. These results indicate that TRIF is an important mediator of inflammation-driven sickness behavior, and should be considered during the development of anti-inflammatory therapies for cachexia.
Several studies investigated the role of MyD88 in sickness behavior (Yamawaki et al., 2010; Braun et al., 2012; Zhu et al., 2016 ), yet evidence suggests that MyD88-independent signaling pathways are important in CNS immune activation (Hosmane et al., 2012; Menasria et al., 2013) . We found that MyD88KO mice still experienced hypothalamic inflammation. It is important to note that while many inflammatory cytokine and chemokine genes were upregulated in LPStreated MyD88KO mice compared to saline-treated MyD88KO mice, the expression of genes in the LPS-treated MyD88KO mice was much lower than that in LPS-treated WT animals. This shows that MyD88 is a key mediator of LPS-induced neuroinflammation, but there are other mediators important in inflammatory gene expression.
While the role of TRIF signaling in acute sickness behavior during viral infection was investigated previously (Zhu et al., 2016; Murray et al., 2015; Gibney et al., 2013) , these studies focused on the effects of a single injection of Poly I:C, a viral double-stranded RNA mimetic, on acute sickness behavior and neuroinflammation. Poly I:C is a known TLR3 agonist and is a model of acute viral illness. Alternatively, this is the first study to investigate the role of TRIF in acute sickness behavior after LPS exposure and during cachexia. After systemic challenge with LPS, TRIFKO mice experienced attenuated anorexia and weight loss compared to WT mice. These results also coincided with an attenuated increase in serum corticosterone, implicating TRIF as a key player in stress response. Furthermore, LPS-treated TRIFKO mice showed attenuated hypothalamic inflammation compared to WT mice. Interestingly, we found that Ifnβ, a key transcript regulated by TRIF signaling, K.G. Burfeind et al. Brain, Behavior, and Immunity xxx (xxxx) xxx-xxx was not induced by LPS exposure or cancer in WT or TRIFKO mice. To our knowledge, this is the first report of Ifnβ gene expression in the hypothalamus after systemic LPS exposure. It is possible Ifnβ was induced earlier than 6 h after LPS exposure, since it was previously shown that Ifnβ mRNA is upregulated in the hippocampus 2 h after 100 μg/kg IP LPS (Skelly et al. 2013) . Future studies should investigate the expression of type I interferons in the hypothalamus at different time points after LPS exposure. In addition to attenuated acute sickness behavior after systemic LPS exposure, TRIFKO mice experienced attenuated anorexia and weight loss after ICV LPS administration. Interestingly, TRIFKO mice showed similar weight loss 12 h after LPS administration, yet recovered more rapidly than WT mice, reaching baseline body weight 36 h after injection. While it has been previously reported that TLR4 is important in neuroinflammation and acute sickness behavior after IP LPS exposure (Hines et al., 2013) , the kinetics of different signaling pathways linked to TLR4 are not known. Our results suggest that in the CNS, MyD88 may drive initial sickness response after TLR4 activation, whereas TRIF signaling may be involved in maintaining inflammation and subsequent sickness response. It should be noted that a repeated measures threeway ANOVA would provide valuable information on the interaction between time, genotype, and treatment status. Unfortunately, our experiments were not sufficiently powered for this analysis. Future studies should investigate the kinetics of TRIF-dependent acute sickness behavior in detail.
In the brain, microglia express TRIF at basal levels, and this expression is enhanced by various CNS insults (Lin et al., 2012; Wang et al., 2013) . Review of the published online database (https://web. stanford.edu/group/barres_lab/brain_rnaseq.html) confirms that the basal expression of TRIF (Ticam1) is predominantly found in microglia (Zhang et al., 2014) . We found that, unlike in WT mice, microglia in TRIFKO mice did not show an increase in Iba-1 intensity in the ME or an increase in Iba-1+ cell size in the ARC 12 h after ICV LPS administration. While additional studies are needed to characterize the functional changes in TRIFKO microglia after LPS exposure, these results are in agreement with previous studies showing that TRIF expression in microglia is required for normal inflammatory activation and phagocytosis in response to neuronal injury (Hosmane et al., 2012; Lin et al., 2012) . Furthermore, in a murine model of intracerebral hemorrhage, TRIFKO mice showed attenuated neurologic disability and neuroinflammation. In addition, TLR2 activation in hypothalamic microglia was shown to generate sickness responses (Jin et al., 2016) . TRIF is now known to be linked to TLR2 signaling (Nilsen et al., 2015; PetnickiOcwieja et al., 2013) . Therefore, our data, in addition to previous findings, suggest TRIF is important in microglial activation during states of inflammation, which is important in driving subsequent functional and behavioral response.
We found that TRIFKO mice experienced attenuated hypothalamic inflammation after systemic LPS exposure. Interestingly, amongst the differentially regulated transcripts between WT and TRIFKO animals, there was a predominance of chemokine mRNAs (Ccl2, Ccl5, Cxcl1, Cxcl10). Previous studies showed that acute LPS exposure results in peripheral immune cell recruitment to the brain (He et al., 2016) and that infiltrating immune cells in the brain drive sickness behavior in states of chronic inflammation (D'Mello et al., 2009 ). Based on these data, we investigated whether TRIFKO mice had decreased immune cell infiltration into the brain after ICV LPS exposure and found that TRIF was required for neutrophil recruitment. Interestingly, we did see a nonsignificant increase in Ly6Chi monocytes. While it is difficult to speculate on trends, it is possible there was a compensatory increase in the cells as a result of TRIF deletion causing an altered inflammatory reaction. While TRIF is known to be important for neutrophil recruitment to the lungs (Liu et al., 2016) , this is the first study to implicate TRIF in neutrophil recruitment to the brain. This presents a novel mechanism that can be applied to several pathologies, including CNS infection, cancer, and stroke. Furthermore, while neutrophils may appear after the onset of initial sickness behaviors in the setting of acute illness, no studies have investigated whether neutrophils are important in sickness behavior or cachexia. In addition, it is important to note that while our flow cytometry results cannot distinguish if the CNS neutrophils have translocated into the brain parenchyma, several lines of evidence demonstrate that adherent intravascular neutrophils contribute to inflammation and pathology in the brain (Atangana et al., 2017; Ruhnau et al., 2017) . Interestingly, brain-infiltrating neutrophils in LPS-treated TRIFKO mice showed a nonsignificant increase in Ly6G expression compared to brain-infiltrating neutrophils in LPS-treated WT mice, sometimes so much so that the Ly6G expression exceeded the predefined "maximum" fluorescent intensity. This suggests that brain-infiltrating neutrophils in TRIFKO mice may have a different phenotype than those in WT mice. More advanced flow cytometry studies (intracellular staining for cytokines and enzymes) and histology studies are needed to further investigate this observation.
When inflammation is maintained, acute sickness behavior transforms into cachexia, a maladaptive condition associated with increased mortality and decreased quality of life during numerous chronic diseases (Bachmann et al., 2008; Wesseltoft-Rao et al., 2015; Lainscak et al., 2007) . While inflammation is critical for cachexia, mechanisms of inflammatory signaling important for this syndrome remain unclear. We found that in a mouse model of PDAC-associated cachexia, TRIFKO mice experienced attenuated anorexia, voluntary LMA, muscle catabolism, and hypothalamic inflammation compared to WT mice. While our results were consistent across various behavioral and molecular measures of cachexia, it is important to note that the effects of Ticam1 deletion were modest. It is important to note that differences in dark cycle home cage LMA between WT tumor and TRIFKO tumor were significant only when analysis was expanded to Three-way ANOVA, a testament to the minor effects of TRIF on this measure of cachexia. These results suggest that other inflammatory signaling pathways are important in cachexia. Rudd et al. previously reported that MyD88KO mice were resistant to anorexia in a methylcholanthrene-induced sarcoma tumor model (Ruud et al., 2010) . However, this was a short report and their analysis of cachexia was limited to food intake and carcass weight.
The main limitation of the present study is the lack of cell specificity in global TRIFKO experiments. Future studies are needed to identify the critical cell type involved in TRIF-mediated sickness behavior and cachexia. Furthermore, we only assessed muscle catabolism only in the gastrocnemius. While gastrocnemius may not be representative of all skeletal muscle, we previously reported that other muscle groups (tibialis anterior, soleus, etc.) showed similar catabolic changes during PDAC cachexia (Michaelis et al., 2017) . In addition, we only used a single measure of stress response (circulating corticosterone levels 4 h after LPS exposure). While a single test is not sufficient to fully define the role of TRIF in stress response, previous studies have shown 4 h circulating corticosterone levels as a robust measure of acute stress response (Pérez-Nievas et al., 2010; Johnson et al., 1996) . In addition, we report results from multiple experiments using different doses ICV LPS administration. We chose a dose sufficient to induce sickness response when injected centrally, but not when injected peripherally (50 ng), and the smallest single dose required to induce neutrophil recruitment to the brain (500 ng, data not shown). While whether or not LPS crosses the blood brain barrier (BBB) remains controversial (Banks and Robinson, 2010) , we believe this route of administration is sufficient for the purpose of this study for two reasons. First, the MBH contains a dramatically attenuated BBB, allowing circulating molecules to access the parenchyma in the region (Rodríguez et al., 2010; Morita and Miyata, 2013) . Second, there are several ways that peripherally administered LPS induces neuroinflammation (acute phase response proteins, platelet mobilization, peripheral immune cell-derived cytokines, vagus nerve activation, etc.) (de Stoppelaar et al., 2014; Le Thuc et al., 2017) . Therefore, we chose to make many of our observations with low-dose LPS delivered centrally to minimize confounders.
Another limitation is the fact that we performed analysis of cachexia using only one mouse model of cancer cachexia. Caution is warranted when applying our results to other types of cachexia (heart failure, cirrhosis, untreated HIV, other types of cancer, etc.). However, this model is extensively characterized (Michaelis et al., 2017) , and recapitulates all of the cardinal features of cachexia seen in humans. Furthermore, it avoids many of the shortcomings in other mouse models of cachexia, including: multiple clones with variable cachexia (Kir et al., 2014) , cachexia driven by only a single cytokine (Talbert et al., 2014) , and requiring advanced surgical techniques to induce cachexia (DeBoer, 2009) . Nevertheless, future studies should assess the effects of Ticam1 deletion in other models of cachexia, as well as the tumor immune response in TRIFKO mice.
In conclusion, we report that TRIF is important in acute sickness behavior and cachexia. These results show that TRIF-dependent mechanisms should be considered when developing therapeutic targets for cachexia. Future studies are needed to identify the important cell types involved in TRIF signaling during acute illness response and cachexia.
